z-logo
open-access-imgOpen Access
PRKAR1AandPDE4DMutations Cause Acrodysostosis but Two Distinct Syndromes with or without GPCR-Signaling Hormone Resistance
Author(s) -
Agnès Linglart,
Helena Fryssira,
Olaf Hiort,
Paul-Martin Holterhus,
Guiomar Pérez de Nanclares,
Jesús Argente,
Claudine Heinrichs,
Alma Kuechler,
Giovanna Mantovani,
Bruno Leheup,
Philippe Wicart,
Virginie Chassot,
Dorothée Schmidt,
Oscar RubioCabezas,
Annette Richter-Unruh,
Sara Berrade,
Arrate Pereda,
Emese Boros,
M.T. Muñoz-Calvo,
Marco Castori,
Yasemin Güneş,
Guylène Bertrand,
Pierre Bougnères,
Éric Clauser,
Caroline Silve
Publication year - 2012
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2012-2326
Subject(s) - mutation , phenotype , biology , genetics , g protein coupled receptor , cancer research , signal transduction , gene
Acrodysostosis is a rare skeletal dysplasia that is associated with multiple resistance to G protein-coupled receptor (GPCR) signaling hormones in a subset of patients. Acrodysostosis is genetically heterogeneous because it results from heterozygous mutations in PRKAR1A or PDE4D, two key actors in the GPCR-cAMP-protein kinase A pathway.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom